MedicineBiology

C. Rébé, Anaïs Perrichet, François Ghiringhelli

2026.2.3OncoImmunology

DOI: 10.1080/2162402x.2026.2622661

Abstract

ABSTRACT Interleukin (IL)-1β is known to promote lung cancer growth in both humans and mice. However, in the context of the current standard of care, which includes chemotherapy and immune checkpoint inhibitors, IL-1β can overcome resistance.

Citation format

RÉBÉ, C.; PERRICHET, Anaïs; GHIRINGHELLI, François. The double face of IL-1β in lung cancer. OncoImmunology, 2026, 15(1): 2622661.